Literature DB >> 11509539

Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells.

M V Gurjar1, J DeLeon, R V Sharma, R C Bhalla.   

Abstract

Vascular smooth muscle (VSM) cell migration is a critical step in the development of a neointima after angioplasty. Matrix metalloproteinases (MMPs) degrade the basement membrane and extracellular matrix, facilitating VSM cell migration. Recently, we demonstrated that nitric oxide (NO) inhibits interleukin-1 beta (IL-1 beta)-stimulated MMP-9 induction in rat aortic VSM cells. In this study, we examined the hypothesis that NO inhibits MMP-9 induction by attenuating superoxide generation and extracellular signal-regulated kinase (ERK) activation. Stimulation of VSM cells with IL-1 beta significantly (P < 0.05) increased superoxide production, ERK activation, and MMP-9 induction. Pretreatment of VSM cells with the NO donor DETA NONOate significantly (P < 0.05) decreased IL-1 beta-stimulated superoxide generation. In addition, pretreatment of VSM cells with a specific ERK pathway inhibitor, PD-98059, or DETA NONOate inhibited IL-1 beta-stimulated ERK activation and MMP-9 induction. Direct exposure of VSM cells to increased superoxide levels by treatment with xanthine/xanthine oxidase increased ERK activation and MMP-9 induction, whereas pretreatment of cells with PD-98059 significantly (P < 0.05) inhibited xanthine/xanthine oxidase-stimulated ERK activation and MMP-9 induction. We conclude that NO inhibits IL-1 beta-stimulated MMP-9 induction by inhibiting superoxide generation and subsequent ERK activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509539     DOI: 10.1152/jappl.2001.91.3.1380

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  13 in total

1.  Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects.

Authors:  Ingrid F Metzger; Valéria C Sandrim; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

Review 2.  Opioids and matrix metalloproteinases: the influence of morphine on MMP-9 production and cancer progression.

Authors:  Samira Khabbazi; Mohammadhossein Hassanshahi; Alireza Hassanshahi; Yaser Peymanfar; Yu-Wen Su; Cory J Xian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-17       Impact factor: 3.000

3.  Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms.

Authors:  Cesar A Meschiari; Tatiane Izidoro-Toledo; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2013-03-03       Impact factor: 3.396

Review 4.  Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium.

Authors:  Deborah A Siwik; Wilson S Colucci
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

5.  Inhibitory effects of lithospermic acid on proliferation and migration of rat vascular smooth muscle cells.

Authors:  Li Chen; Wen-yi Wang; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

6.  Ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions increase levels of nitric oxide and matrix metalloproteinase-9 without a direct association between them.

Authors:  Hideaki Yamaguchi; Yumi Kidachi; Hironori Umetsu; Kazuo Ryoyama
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

Review 7.  Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

Authors:  Somnath Mukhopadhyay; David A Tulis
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-10

Review 8.  Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies.

Authors:  Allyn C Howlett; Somnath Mukhopadhyay; Derek C Norford
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-24       Impact factor: 4.147

Review 9.  Redox signaling, vascular function, and hypertension.

Authors:  Moo Yeol Lee; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2008-06       Impact factor: 8.401

10.  L-NAME inhibits tumor cell progression and pulmonary metastasis of r/m HM-SFME-1 cells by decreasing NO from tumor cells and TNF-alpha from macrophages.

Authors:  Hideaki Yamaguchi; Yumi Kidachi; Hironori Umetsu; Kazuo Ryoyama
Journal:  Mol Cell Biochem       Date:  2008-03-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.